Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
L'Encephale
|
June 22, 2005
[The methodology of the studies in the treatment of maniac admissions]
A C Altamura
Clinical Neuropharmacology
|
January 1, 1990
Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms
A C Altamura
International Clinical Psychopharmacology
|
September 1, 1996
Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds?
A C Altamura
Biological Psychiatry
|
September 15, 1996
Hypothalamic-pituitary-adrenal axis in schizophrenia
A C Altamura
International Journal of Psychiatry in Clinical Practice
|
June 14, 2014
A new philosophy for schizophrenia care
A C Altamura
Schizophrenia Research
|
January 1, 1993
A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance
A C Altamura
Acta Psychiatrica Scandinavica
|
November 1, 1975
Therapeutic attempts with lithium in young drug addicts
A C Altamura
Clinical Neuropharmacology
|
January 1, 1992
Relevance of pharmacokinetic studies on antipsychotics in the management of schizophrenic disorders
A C Altamura
British Journal of Clinical Pharmacology
|
December 1, 1985
Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants
A C Altamura, M Mauri
The Journal of Clinical Psychiatry
|
August 1, 1993
The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directions
A C Altamura, M Percudani
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
L'Encephale
|
June 22, 2005
[The methodology of the studies in the treatment of maniac admissions]
A C Altamura
Clinical Neuropharmacology
|
January 1, 1990
Drug-resistance phenomena in major psychoses: their discrimination and causal mechanisms
A C Altamura
International Clinical Psychopharmacology
|
September 1, 1996
Novel antipsychotics and the problem of clinical stabilization in schizophrenia: are they "stabilizer" rather than typical compounds?
A C Altamura
Biological Psychiatry
|
September 15, 1996
Hypothalamic-pituitary-adrenal axis in schizophrenia
A C Altamura
International Journal of Psychiatry in Clinical Practice
|
June 14, 2014
A new philosophy for schizophrenia care
A C Altamura
Schizophrenia Research
|
January 1, 1993
A multidimensional (pharmacokinetic and clinical-biological) approach to neuroleptic response in schizophrenia. With particular reference to drug resistance
A C Altamura
Acta Psychiatrica Scandinavica
|
November 1, 1975
Therapeutic attempts with lithium in young drug addicts
A C Altamura
Clinical Neuropharmacology
|
January 1, 1992
Relevance of pharmacokinetic studies on antipsychotics in the management of schizophrenic disorders
A C Altamura
British Journal of Clinical Pharmacology
|
December 1, 1985
Plasma concentrations, information and therapy adherence during long-term treatment with antidepressants
A C Altamura, M Mauri
The Journal of Clinical Psychiatry
|
August 1, 1993
The use of antidepressants for long-term treatment of recurrent depression: rationale, current methodologies, and future directions
A C Altamura, M Percudani
Page
of 12